{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:03:18Z","timestamp":1793124198594,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["A2024395"],"award-info":[{"award-number":["A2024395"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08634-7","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:07:58Z","timestamp":1751368078000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Disease burden of bladder cancer in China and the different SDI regions over the world from 1990 to 2021"],"prefix":"10.1038","volume":"15","author":[{"given":"Xiaosheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizhe","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peidong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huirong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"8634_CR1","unstructured":"Ferlay J et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer, https:\/\/gco.iarc.who.int\/today (2024)."},{"key":"8634_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"8634_CR3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay, J. et al. Cancer statistics for the year 2020: An overview. Int. J. Cancer 149, 778\u2013789. https:\/\/doi.org\/10.1002\/ijc.33588 (2021).","journal-title":"Int. J. Cancer"},{"key":"8634_CR4","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis, A. T., Lec, P. M., Chamie, K. & Mshs, M. D. Bladder cancer: A review. JAMA 324, 1980\u20131991. https:\/\/doi.org\/10.1001\/jama.2020.17598 (2020).","journal-title":"JAMA"},{"key":"8634_CR5","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia, C. et al. Cancer statistics in China and United States, 2022: Profiles, trends, and determinants. Chin. Med. J. (Engl.) 135, 584\u2013590. https:\/\/doi.org\/10.1097\/CM9.0000000000002108 (2022).","journal-title":"Chin. Med. J. (Engl.)"},{"key":"8634_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han, B. et al. Cancer incidence and mortality in China, 2022. Journal of the National Cancer Center 4, 47\u201353. https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006 (2024).","journal-title":"Journal of the National Cancer Center"},{"key":"8634_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3760\/cma.j.cn112152-20200421-00362","volume":"43","author":"HZ Li","year":"2021","unstructured":"Li, H. Z. et al. Bladder cancer incidence, mortality and temporal trends in China. Zhonghua zhong liu za zhi [Chinese journal of oncology] 43, 293\u2013298. https:\/\/doi.org\/10.3760\/cma.j.cn112152-20200421-00362 (2021).","journal-title":"Zhonghua zhong liu za zhi [Chinese journal of oncology]"},{"key":"8634_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-90229-3","author":"X Chen","year":"2025","unstructured":"Chen, X. et al. Comprehensive analysis of the global, regional, and national burden of benign prostatic hyperplasia from 1990 to 2021. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-025-90229-3 (2025).","journal-title":"Sci. Rep."},{"key":"8634_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40779-024-00569-w","volume":"11","author":"H Zi","year":"2024","unstructured":"Zi, H. et al. Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Mil. Med. Res. 11, 64. https:\/\/doi.org\/10.1186\/s40779-024-00569-w (2024).","journal-title":"Mil. Med. Res."},{"key":"8634_CR10","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","volume":"394","author":"M Zhou","year":"2019","unstructured":"Zhou, M. et al. Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 394, 1145\u20131158. https:\/\/doi.org\/10.1016\/S0140-6736(19)30427-1 (2019).","journal-title":"Lancet"},{"key":"8634_CR11","doi-asserted-by":"publisher","first-page":"e34114","DOI":"10.1016\/j.heliyon.2024.e34114","volume":"10","author":"J Yuan","year":"2024","unstructured":"Yuan, J. et al. Global burden of bladder cancer attributable to smoking in 204 countries and territories, 1990\u20132019. Heliyon 10, e34114. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34114 (2024).","journal-title":"Heliyon"},{"key":"8634_CR12","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"GBD Diseases","year":"2024","unstructured":"Diseases, G. B. D. & Injuries, C. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet 403, 2133\u20132161. https:\/\/doi.org\/10.1016\/S0140-6736(24)00757-8 (2024).","journal-title":"Lancet"},{"key":"8634_CR13","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"F Catal\u00e1-L\u00f3pez","year":"2024","unstructured":"Catal\u00e1-L\u00f3pez, F., Padron-Monedero, A., Sarmiento Su\u00e1rez, R., 2021, GDB Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet 403, 2100\u20132132. https:\/\/doi.org\/10.1016\/S0140-6736(24)00367-2 (2024).","journal-title":"Lancet"},{"key":"8634_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijso.2021.100430","author":"G Mathew","year":"2021","unstructured":"Mathew, G. & Agha, R. STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int. J. Surg. Open https:\/\/doi.org\/10.1016\/j.ijso.2021.100430 (2021).","journal-title":"Int. J. Surg. Open"},{"key":"8634_CR15","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","volume":"388","author":"GA Stevens","year":"2016","unstructured":"Stevens, G. A. et al. Guidelines for accurate and transparent health estimates reporting: The GATHER statement. Lancet 388, e19\u2013e23. https:\/\/doi.org\/10.1016\/S0140-6736(16)30388-9 (2016).","journal-title":"Lancet"},{"key":"8634_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim, H. J., Fay, M. P., Feuer, E. J. & Midthune, D. N. Permutation tests for joinpoint regression with applications to cancer rates. Stat. Med. 19, 335\u2013351. https:\/\/doi.org\/10.1002\/(sici)1097-0258(20000215)19:3%3c335::aid-sim336%3e3.0.co;2-z (2000).","journal-title":"Stat. Med."},{"key":"8634_CR17","doi-asserted-by":"publisher","first-page":"106250","DOI":"10.1016\/j.jinf.2024.106250","volume":"89","author":"D Huang","year":"2024","unstructured":"Huang, D. et al. Global temporal trends and projections of acute hepatitis E incidence among women of childbearing age: Age-period-cohort analysis 2021. J. Infect. 89, 106250. https:\/\/doi.org\/10.1016\/j.jinf.2024.106250 (2024).","journal-title":"J. Infect."},{"key":"8634_CR18","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1158\/1055-9965.EPI-14-0300","volume":"23","author":"PS Rosenberg","year":"2014","unstructured":"Rosenberg, P. S., Check, D. P. & Anderson, W. F. A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol. Biomark. Prevent.: Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prevent. Oncol. 23, 2296\u20132302. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-0300 (2014).","journal-title":"Cancer Epidemiol. Biomark. Prevent.: Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prevent. Oncol."},{"key":"8634_CR19","first-page":"171","volume":"50","author":"P Das Gupta","year":"1994","unstructured":"Das Gupta, P. Standardization and decomposition of rates from cross-classified data. Genus 50, 171\u2013196 (1994).","journal-title":"Genus"},{"key":"8634_CR20","doi-asserted-by":"publisher","first-page":"31787","DOI":"10.1038\/s41598-024-82897-4","volume":"14","author":"S Yu","year":"2024","unstructured":"Yu, S. et al. Global burden and trends of testicular cancer in adolescents and young adults from 1990 to 2021, with predictions to 2035. Sci. Rep. 14, 31787. https:\/\/doi.org\/10.1038\/s41598-024-82897-4 (2024).","journal-title":"Sci. Rep."},{"key":"8634_CR21","doi-asserted-by":"publisher","first-page":"29034","DOI":"10.3402\/gha.v8.29034","volume":"8","author":"AR Hosseinpoor","year":"2015","unstructured":"Hosseinpoor, A. R., Bergen, N. & Schlotheuber, A. Promoting health equity: WHO health inequality monitoring at global and national levels. Glob. Health Act. 8, 29034. https:\/\/doi.org\/10.3402\/gha.v8.29034 (2015).","journal-title":"Glob. Health Act."},{"key":"8634_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/bimj.201500263","volume":"59","author":"A Riebler","year":"2017","unstructured":"Riebler, A. & Held, L. Projecting the future burden of cancer: Bayesian age-period-cohort analysis with integrated nested Laplace approximations. Biom J. 59, 531\u2013549. https:\/\/doi.org\/10.1002\/bimj.201500263 (2017).","journal-title":"Biom J."},{"key":"8634_CR23","doi-asserted-by":"publisher","first-page":"107327482311523","DOI":"10.1177\/10732748231152322","volume":"30","author":"W Lin","year":"2023","unstructured":"Lin, W., Pan, X., Zhang, C., Ye, B. & Song, J. Impact of age at diagnosis of bladder cancer on survival: A surveillance, epidemiology, and end results-based study 2004\u20132015. Cancer Control 30, 10732748231152322. https:\/\/doi.org\/10.1177\/10732748231152322 (2023).","journal-title":"Cancer Control"},{"key":"8634_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.arr.2015.08.003","volume":"24","author":"EF Fang","year":"2015","unstructured":"Fang, E. F. et al. A research agenda for aging in China in the 21st century. Ageing Res. Rev. 24, 197\u2013205. https:\/\/doi.org\/10.1016\/j.arr.2015.08.003 (2015).","journal-title":"Ageing Res. Rev."},{"key":"8634_CR25","doi-asserted-by":"publisher","first-page":"e042762","DOI":"10.1136\/bmjopen-2020-042762","volume":"11","author":"S Yuan","year":"2021","unstructured":"Yuan, S. & Xie, S. H. Urban-rural disparity in cancer incidence in China, 2008\u20132012: A cross-sectional analysis of data from 36 cancer registers. BMJ Open 11, e042762. https:\/\/doi.org\/10.1136\/bmjopen-2020-042762 (2021).","journal-title":"BMJ Open"},{"key":"8634_CR26","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1186\/s12889-024-19909-5","volume":"24","author":"LS Luo","year":"2024","unstructured":"Luo, L. S. et al. The disease burden of bladder cancer and its attributable risk factors in five Eastern Asian countries, 1990\u20132019: A population-based comparative study. BMC Public Health 24, 2404. https:\/\/doi.org\/10.1186\/s12889-024-19909-5 (2024).","journal-title":"BMC Public Health"},{"key":"8634_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/tobaccocontrol-2021-056535","volume":"31","author":"X Dai","year":"2022","unstructured":"Dai, X., Gakidou, E. & Lopez, A. D. Evolution of the global smoking epidemic over the past half century: Strengthening the evidence base for policy action. Tob. Control 31, 129\u2013137. https:\/\/doi.org\/10.1136\/tobaccocontrol-2021-056535 (2022).","journal-title":"Tob. Control"},{"key":"8634_CR28","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"GBDRF Collaborators","year":"2020","unstructured":"Collaborators, G. B. D. R. F. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1223\u20131249. https:\/\/doi.org\/10.1016\/S0140-6736(20)30752-2 (2020).","journal-title":"Lancet"},{"key":"8634_CR29","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2147\/CLEP.S387289","volume":"14","author":"Z Xiang","year":"2022","unstructured":"Xiang, Z., Ye, Z., Ma, J., Lin, Y. & Zhou, Y. Temporal trends and projections of Bladder cancer burden in China from 1990 to 2030: Findings from the global burden of disease study. Clin Epidemiol 14, 1305\u20131315. https:\/\/doi.org\/10.2147\/CLEP.S387289 (2022).","journal-title":"Clin Epidemiol"},{"key":"8634_CR30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3233\/blc-230062","volume":"9","author":"IR Pompa","year":"2023","unstructured":"Pompa, I. R. et al. Longitudinal analysis of bladder cancer-specific mortality trends in the United States. Bladder Cancer 9, 345\u2013353. https:\/\/doi.org\/10.3233\/blc-230062 (2023).","journal-title":"Bladder Cancer"},{"key":"8634_CR31","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1186\/s12885-022-10244-9","volume":"22","author":"Q Huang","year":"2022","unstructured":"Huang, Q. et al. Secular trends of morbidity and mortality of prostate, bladder, and kidney cancers in China, 1990 to 2019 and their predictions to 2030. BMC Cancer 22, 1164. https:\/\/doi.org\/10.1186\/s12885-022-10244-9 (2022).","journal-title":"BMC Cancer"},{"key":"8634_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.canep.2019.05.011","volume":"61","author":"X Liu","year":"2019","unstructured":"Liu, X. et al. Secular trends in incidence and mortality of bladder cancer in China, 1990\u20132017: A joinpoint and age-period-cohort analysis. Cancer Epidemiol. 61, 95\u2013103. https:\/\/doi.org\/10.1016\/j.canep.2019.05.011 (2019).","journal-title":"Cancer Epidemiol."},{"key":"8634_CR33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni, S. et al. Bladder cancer incidence and mortality: A global overview and recent trends. Eur. Urol. 71, 96\u2013108. https:\/\/doi.org\/10.1016\/j.eururo.2016.06.010 (2017).","journal-title":"Eur. Urol."},{"key":"8634_CR34","doi-asserted-by":"publisher","first-page":"7655","DOI":"10.1038\/s41598-025-92033-5","volume":"15","author":"X Su","year":"2025","unstructured":"Su, X., Tao, Y., Chen, F., Han, X. & Xue, L. Trends in the global, regional, and national burden of bladder cancer from 1990 to 2021: An observational study from the global burden of disease study 2021. Sci. Rep. 15, 7655. https:\/\/doi.org\/10.1038\/s41598-025-92033-5 (2025).","journal-title":"Sci. Rep."},{"key":"8634_CR35","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1186\/s12889-024-18353-9","volume":"24","author":"Q Huang","year":"2024","unstructured":"Huang, Q. et al. Changes in disease burden and global inequalities in bladder, kidney and prostate cancers from 1990 to 2019: A comparative analysis based on the global burden of disease study 2019. BMC Public Health 24, 891. https:\/\/doi.org\/10.1186\/s12889-024-18353-9 (2024).","journal-title":"BMC Public Health"},{"key":"8634_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.puhe.2024.07.027","volume":"236","author":"LY Zhang","year":"2024","unstructured":"Zhang, L. Y., Wang, P., Wang, Y. B. & He, Z. Q. Global, regional, and national burden of bladder cancer, 1990\u20132019: An age-period-cohort analysis based on the Global Burden of Disease 2019 study. Public Health 236, 193\u2013203. https:\/\/doi.org\/10.1016\/j.puhe.2024.07.027 (2024).","journal-title":"Public Health"},{"key":"8634_CR37","doi-asserted-by":"publisher","first-page":"6875","DOI":"10.1002\/cam4.3338","volume":"9","author":"J Fan","year":"2020","unstructured":"Fan, J. et al. Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017. Cancer Med. 9, 6875\u20136887. https:\/\/doi.org\/10.1002\/cam4.3338 (2020).","journal-title":"Cancer Med."},{"key":"8634_CR38","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jamapediatrics.2015.4276","volume":"170","author":"C Global Budeb of Disease Pediatrics","year":"2016","unstructured":"Global Budeb of Disease Pediatrics, C. et al. Global and national burden of diseases and injuries among children and adolescents between 1990 and 2013: Findings from the global burden of disease 2013 study. JAMA Pediatr. 170, 267\u2013287. https:\/\/doi.org\/10.1001\/jamapediatrics.2015.4276 (2016).","journal-title":"JAMA Pediatr."},{"key":"8634_CR39","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LMC van Hoogstraten","year":"2023","unstructured":"van Hoogstraten, L. M. C. et al. Global trends in the epidemiology of bladder cancer: Challenges for public health and clinical practice. Nat. Rev. Clin. Oncol. 20, 287\u2013304. https:\/\/doi.org\/10.1038\/s41571-023-00744-3 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"8634_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13027-023-00491-1","volume":"18","author":"C Yohana","year":"2023","unstructured":"Yohana, C., Bakuza, J. S., Kinung\u2019hi, S. M., Nyundo, B. A. & Rambau, P. F. The trend of schistosomiasis related bladder cancer in the lake zone, Tanzania: A retrospective review over 10 years period. Infect. Agent Cancer 18, 10. https:\/\/doi.org\/10.1186\/s13027-023-00491-1 (2023).","journal-title":"Infect. Agent Cancer"},{"key":"8634_CR41","doi-asserted-by":"publisher","first-page":"485","DOI":"10.37029\/jcas.v9i1.485","volume":"9","author":"R Shadab","year":"2023","unstructured":"Shadab, R., Nerli, R. B., Bidi, S. R. & Ghagane, S. C. Risk factors for bladder cancer: Results of a survey of hospital patients. J. Cancer Allied Spec. 9, 485. https:\/\/doi.org\/10.37029\/jcas.v9i1.485 (2023).","journal-title":"J. Cancer Allied Spec."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08634-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08634-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08634-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:08:02Z","timestamp":1751368082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08634-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8634"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08634-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20811"}}